The AI-biotech hype cycle promised miracle drugs by 2026. Labs got chatbots, hallucinated drug targets, and pressure to 'integrate ML' into everything. Zero AI-designed drugs approved. The grift meets reality.
The $700 juicer that could be out-squeezed by human hands — Juicero's spectacular flameout is the ultimate cautionary tale of Silicon Valley hype.
Perplexity AI, the $3B 'answer engine,' caught running scrapers disguised as regular browsers to steal content. CEO Aravind Srinivas's company is bypassing robots.txt and lying about user agents. The AI grift continues.
Apple's $3,499 spatial computing face-hammock got the WSJ review treatment. Spoiler: it's a masterclass in solving problems nobody has, with a price tag that screams 'I have more money than sense.'
Boston Dynamics got flipped again — this time to Hyundai for $921M. Three owners in seven years for a robot dog company that sells fewer units than a Supreme drop. Peak hype-cycle theater.
Solar panels that split water into hydrogen using nothing but sunlight seem like the ultimate clean energy fantasy. But with AI data centers now consuming more power than nations, this might be the worst possible time to dismiss it.
DALL-E 3 vs Imagen 2: the AI image generation bloodbath tearing Reddit apart. One plays it safe, one chases aesthetics, and Midjourney's just vibing in the corner eating everyone's lunch.
Jeffrey Snover's right: Microsoft's 30-year GUI framework graveyard proves they haven't had a coherent strategy since Petzold. Now they want AI to replace UI entirely. Bad idea.
Five years after someone called GPT-3 'bigger than Bitcoin,' we've got AI deleting databases in 9 seconds, Meta keylogging employees to train replacements, and Kevin O'Leary building a 9GW server farm in Utah. The hype was real. The outcomes are chaos.
Stanford researchers handed an LLM a DNA sequence and it generated 16 functional novel viruses, including one with a protein that doesn't exist in nature. The AI biosecurity era has arrived.